A novel inhibitor of inflammatory cytokine production (CNI-1493) reduces rodent post-hemorrhagic vasospasm

Neurocritical Care

Volumn 5, Issue 3, 2006, Pages 222-229

  Bowman, George ^a   Bonneau, Robert H ^a   Chinchilli, Vernon M ^a   Tracey, Kevin J ^b   Cockroft, Kevin M ^a,c  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^c PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

Cerebral vasospasm; Inflammation; Interleukin 6; Rat femoral artery model; Subarachnoid hemorrhage

Indexed keywords

INTERLEUKIN 6; SEMAPIMOD; TRANSFORMING GROWTH FACTOR BETA1;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRAIN HEMORRHAGE; BRAIN VASOSPASM; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG EFFECT; DRUG MEGADOSE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL MODEL; FEMORAL ARTERY; IMAGE ANALYSIS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; TREATMENT OUTCOME; VASOSPASM;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HYDRAZONES; INJECTIONS, INTRA-ARTERIAL; INTERLEUKIN-6; MALE; RATS; RATS, SPRAGUE-DAWLEY; SUBARACHNOID HEMORRHAGE; TRANSFORMING GROWTH FACTOR BETA1; VASOSPASM, INTRACRANIAL;

EID: 33846961135     PISSN: 15416933     EISSN: None     Source Type: Journal    
DOI: 10.1385/NCC:5:3:222     Document Type: Article

References (48)

1. Mathiesen T, Edner G, Ulfarsson E, Andersson B. Cerebrospinal fluid interleukin-1 receptor antagonist and tumor necrosis factor-alpha following subarachnoid hemorrhage. J Neurosurg 1997;87:215-220.
2. Fassbender K, Hodapp B, Rossol S, et al. Inflammatory cytokines in subarachnoid haemorrhage: association with abnormal blood flow velocities in basal cerebral arteris. J Neurol Neurosurg Psychiatry 2001;70:534-537.
3. Gaetani P, Tancioni F, Grignani G, et al. Platelet derived growth factor and subarachnoid haemorrage: a study on cisternal cerebrospinal fluid. Acta Neurochir 1997;139:319-324.
4. Hirashima Y, Nakamura S, Endo S, Kuwayama N, Naruse Y, Takaku A. Elevation of platelet activating factor, inflammatory cytokines and coagulation factors in the internal jugular vein of patients with subarachnoid hemorrhage. Neurochem Res 1997;22:1249-1255.
5. Kikuchi T, Okuda Y, Kaito N, Abe T. Cytokine production in cerebrospinal fluid after subarachnoid haemorrhage. Neurol Res 1995;17:106-108.
6. Bavbek M, Polin R, Kwan AL, Arthur AS, Kassel N, Lee K. Monoclonal antibodies against ICAM-1 and CD18 attenuate cerebral vasospasm after subarachnoid hemorrhage in rabbits. Stroke 1998;29:1935-1936.
7. Oshiro E, Hoffman P, Dietsch G, Watts M, Pardoll D, Tamargo R. Inhibition of experimental vasospasm with anti-intercellular adhesion moleclue-1 monoclonal antibody in rats. Stroke 1997;28:2031-2038.
8. Bowman G, Dixit S, Bonneau RH, Chinchilli VM, Cockroft KM. Neutralizing antibody against interleukin-6 attenuates posthemorrhagic vasospasm in the rat femoral artery model. Neurosurgery 2004;54:719-725.
9. Bjork L, Tracey KJ, Ulrich P, et al. Targeted suppression of cytokine production in monocytes but not in T lymphocytes by a tetravalent guanylhydrazone (CNI-1493). J Infect Dis 1997;176:1303-1312.
10. Bianchi M, Bloom O, Raabe T, et al. Suppression of proinflammatory cytokines in moncytes by a tetravalent guanylhydrazone. J Exp Med 1996;183:927-936.
11. Okada T, Harada T, Bark D, Mayberg M. A rat femoral artery model for vasospasm. Neurosurgery 1990;27:349-356.
12. Onodo K, Ono S, Ogihara K, et al. Role of extracellular matrix in experimental vasospasm. Inhibitory effect of antisense oligonucleotide on collagen induction. Stroke 1996;27:2102-2108.
13. Macdonald R, Zhang J, Weir B, Marton L, Wollman R. Adenosine triphosphate causes vasospasm of the rat femoral artery. Neurosurgery 1998;42:825-832.
14. Hochberg Y. A sharper Bonferroni procedure for multiple tests of significance. Biometrika 1988;75:800-802.
15. Gaetani P, Tartara F, Pignatti P, Tancioni F, Rodriguez y Baena R, De Benedetti F. Cisternal CSF levels of cytokines after subarachnoid hemorrhage. Neurol Res 1998;20:337-342.
16. Polin R, Bavbek M, Shaffrey M, et al. Detection of soluble E-selectin, ICAM-1, VCAM-1, and L-selectin in the cerebrospinal fluid of patients after subarachnoid hemorrhage. J Neurosurg 1998;89:559-567.
17. Sills A, Clatterbuck R, Thompson R, Cohen P, Tamargo R. Endothelial cell expression of intercellular adhesion molecule 1 in experimental posthemorrhagic vasospasm. Neurosurgery 1997;41:453-460.
18. Thai Q, Oshiro E, Tamargo R. Inhibition of experimental vasospasm in rats with the periadventitial administration of ibuprofen using controlled-released polymers. Stroke 1999;30:140-147.
19. Megyesi J, Vollrath B, Cook D, Findlay J. In vivo animal models of cerebral vasospasm: a review. Neurosurgery 2000;46:448-460.
20. Bianchi M, Ulrich P, Meistrell M III, et al. An inhibitor of macrophage arginine transport and nitric oxide production (CNI-1493) prevents acute inflammatory and endotoxin lethality. Mol Med 1995;3:254-266.
21. Meistrell ME, Botchkina GI, Wang H, et al. Tumor necrosis factor is a brain damaging cytokine in cerebral ischemia. Shock 1997;8:341-348.
22. Milligan ED, O'Connor KA, Armstrong CB, et al. Systemic administration of CNI-1493, a p38 mitogen-activated protein kinase inhibitor, blocks intrathecal human imminodeficiency virus-1 gp120-induced enhanced pain states in rats. J Pain 2001;2:326-333.
23. Milligan ED, Twining C, Chacur M, et al. Spinal glia and proinflammatory cytokines mediate mirro-image neuropathic pain in rats. J Neurosci 2003;23:1026-1040.
24. Granert C, Abdalla H, Lindquist L, et al. Suppression of macrophage activation with CNI-1493 increases survival in infant rats with systemic Haemophilus influenzae infection. Infect Immun 2000;68:5329-5334.
25. Denham W, Yang J, Wang H, Botchkina G, Tracey KJ, Norman J. Inhibition of p38 mitogen activate kinase attenuates the severity pancreatitis-induced adult respiratory distress syndrome. Crit Care Med 2000;28:2567-2572.
26. D'Souza MJ, Oettinger CW, Milton GV, Tracey KJ. Prevention of lethality and suppression of proinflammatory cytokines in experimental septic shock by microencapsulated CNI-1493. J Interferon Cytokine Res 1999;19:1125-1133.
27. Molina PE, Quian L, Schuhlein D, et al. CNI-1493 attenuates hemodynamic and pro-inflammatory responses to LPS. Shock 1998;10:329-334.
28. Yang J, Denham W, Carter G, Tracey KJ, Norman J. Macrophage pacification reduces rodent pancreatitis-induced hepatocellular injury through down-regulation of hepatic tumor necrosis factor alpha and interleukin-1 beta. Hepatology 1998;28:1282-1288.
29. Yang J, Denham W, Tracey KJ, et al. The physiologic consequences of macrophage pacification during severe acute pancreatitis. Shock 1998;10:169-175.
30. Yang X, Szaboles M, Minanov O, et al. CNI-1493 prolongs survival and reduces myocyte loss, apoptosis and inflammation during rat cardiac allograft rejection. J Cardiovasc Pharmacol 1998;32:146-155.
31. Hyon SH, Tracey KJ, Kaufman DB. Specific inhibition of macrophage-derived proinflammatory cytokine synthesis with a tetravalent guyanlhydrazone CNI-1493 accelerates early islet graft function posttransplant. Transplant Proc 1998;30:409-410.
32. Atkins MB, Redman B, Mier J, et al. A phase I study of CNI-1493, an inhibitor of cytokine release, in conjunction with high-dose interleukin-2 in patients with renal cancer and melamoma. Clin Cancer Res 2001;7:486-492.
33. Hommes D, van den Blink B, Plasse T, et al. Inhibition of stress-activated MAP kinases induces clinical improvement to severe Crohn's disease. Gastroenterology 2002;122:7-14.
34. Osuka K, Suzuki Y, Tanazawa T, et al. Interleukin-6 and development of vasospasm after subarachnoid haemorrhage. Acta Neurochir 1998;140:943-951.
35. Fassbender K, Hodapp B, Rossol S, et al. Endothelin-1 in subarachnoid hemorrhage: An acute-phase reactant produced by cerebrospinal fluid leukocytes. Stroke 2000;31:2971-2975.
36. Fujimori A, Yanagisawa M, Saito A, et al. Endolethin in plasma and cerebrospinal fluid of patients with subarachnoid haemorrhage. Lancet 1991;336:633.
37. Gaetani P, Rodriguez y Baena R, Grignani G, Sapanu G, Pacchiarini L, Paoletti P. Endothelin and aneurysmal subarachnoid. J Neurol Neurosurg Psychiatry 1994;57:66-72.
38. Hino A, Weir B, Macdonald R, Thisted R, Kim C, Johns L. Prospective, randomized, double-blind trial of BQ-123 and bosentan for prevention of vasospasm following subarachnoid hemorrhage in monkeys. J Neurosurg 1995;83:503-509.
39. Dietrich H, Dacey R. Molecular keys to the problems of cerebral vasospasm. Neurosurgery 2000;46:517-530.
40. Nathan C. Secretory products of macrophages. J Clin Invest 1987;79:319-326.
41. Calderon T, Sherman J, Wilkerson H, Hatcher V, Bernan J. Interleukin 6 modulates c-sis gene expression in cultured human endothelial cells. Cell Immunol 1992;143:118-126.
42. 2 production in cultured bovine vascular endothelial cells. Arch Biochem Biophys 1992;292:600-604.
43. Chyatte D, Rusch N, Sundt TJ. Prevention of chronic experimental cerebral vasospasm with ibuprofen and high-dose methylprednisolone. J Neurosurg 1983;59:925-932.
44. Chyatte D, Fode N, Nichols D, Sundt TJ. Preliminary report: effects of high dose methylprednisolone on delayed cerebral ischemia in patients at high risk for vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurgery 1987;21:157-160.
45. Chyatte D, Sundt T Jr. Response of chronic experimental cerebral vasospasm to methylprednisolone and dexamethasone. J Neurosurg 1984;60:923-926.
46. Bernik TR, Friedman SG, Ochani M, et al. Pharmacological stimulation of the cholinergic antiinflammatory pathway. J Exp Med 2002;195:781-788.
47. Borovikova LV, Ivanova S, Nardi D, et al. Role of vagus nerve signaling in CNI-1493-mediated suppression of acute inflammation. Auton Neurosci 2000;85:141-147.
48. Watkins LR, Martin D, Ulrich P, Tracey KJ, Maier SF. Evidence for the involvement of spinal cord glia in subcutaneous formalin induced hyperalgesia in the rat. Pain 1997;71:225-235.